Responses
Regular and young investigator award abstracts
Novel single-agent immunotherapies
709 Exosome surface display of IL-12 results in tumor-retained pharmacology with superior potency and limited systemic exposure
Compose a Response to This Article
Other responses
No responses have been published for this article.
